VEEV

VeevaA

NYSE / Health Care Equipment & Services

Quote time unavailable

View Chart

AI scenario view

RankAlpha Sentiment Codex

B+

Bull case

25%

Probability

Target price

$330.00

Analysis reference price unavailable

Analysis 2026-09-09 · RankAlpha Sentiment Codex

Most likely

Base case

50%

Probability

Target price

$292.00

Analysis reference price unavailable

Analysis 2026-09-09 · RankAlpha Sentiment Codex

B-

Bear case

25%

Probability

Target price

$225.00

Analysis reference price unavailable

Analysis 2026-09-09 · RankAlpha Sentiment Codex

The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented

AI sentiment snapshot

Latest data as of 2026-09-09

AI commentary

Official Q2 results and management commentary are clearly positive, but the supplied post-print analyst revision set and price-reaction attribution are unavailable. Secondary headlines are mixed and social coverage is absent, so sentiment supports a monitoring-positive view rather than a high-conviction upgrade. [#SEC-8K-2026-08-26]

RankAlpha Sentiment Codex - 2026-09-09

Open full AI memo

Evidence flagged

peer set is too generic or lacks enough direct operating comparators

Impact

tentative

Confidence

AI events

2026-08-26eventQ2 FY2027 results exceeded guidanceMedium impact

Veeva reported Q2 revenue of $928.0 million, up 18% year over year, subscription revenue of $766.8 million, up 16%, and non-GAAP operating income of $415.9 million, up 18%. Management said results exceeded guidance and the full-year view improved across the board. [#SEC-8K-2026-08-26]

2026-12-31eventVeeva Falcon initial go-livesMedium impact

Falcon is moving quickly with five early adopters and is on track for initial go-lives during 2026. Execution and conversion from early adoption into material recurring revenue remain unproven. [#SEC-8K-2026-08-26] [#REL-a69f20cc-abce-4c34-8185-b6c46ee86f2f]

2026-12-31catalystVault CRM and cross-cloud adoption expansionHigh impact

More than 180 Vault CRM customers were live, including five top-20 biopharmas, while a top-20 biopharma deployed Vault CRM and the Agentic Call Report across its full U.S. field team. Development Cloud, Quality Cloud, and Veeva Safety also showed adoption breadth, though customer economics are undisclosed. [#SEC-8K-2026-08-26] [#REL-48e8506a-99d0-43aa-baf1-1fff9a38099d] [#REL-a84aa2b0-27cd-41f2-9c3c-eeac8a2382d0] [#REL-0db95f67-6157-4abe-96f4-6b4fda138e16] [#REL-e1503cb3-d54d-4635-9190-cd3e5f9c9206]

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-09-09 • Updated nightlySource: Internal modelMethodology